Canada · Delayed Price · Currency is CAD LSL Pharma Group Statistics
Total Valuation
TSXV:LSL has a market cap or net worth of CAD 47.28 million. The enterprise value is 68.88 million.
| Market Cap | 47.28M |
| Enterprise Value | 68.88M |
Important Dates
The last earnings date was Tuesday, November 25, 2025.
| Earnings Date | Nov 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:LSL has 121.22 million shares outstanding. The number of shares has increased by 19.11% in one year.
| Current Share Class | 121.22M |
| Shares Outstanding | 121.22M |
| Shares Change (YoY) | +19.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 28.55% |
| Owned by Institutions (%) | n/a |
| Float | 78.49M |
Valuation Ratios
The trailing PE ratio is 17.19.
| PE Ratio | 17.19 |
| Forward PE | n/a |
| PS Ratio | 1.76 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 24.82 |
| EV / Sales | 2.57 |
| EV / EBITDA | 17.17 |
| EV / EBIT | 48.68 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.53 |
| Quick Ratio | n/a |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 5.39 |
| Debt / FCF | n/a |
| Interest Coverage | 0.53 |
Financial Efficiency
Return on equity (ROE) is 12.13% and return on invested capital (ROIC) is 2.17%.
| Return on Equity (ROE) | 12.13% |
| Return on Assets (ROA) | 1.80% |
| Return on Invested Capital (ROIC) | 2.17% |
| Return on Capital Employed (ROCE) | 3.03% |
| Revenue Per Employee | 144,108 |
| Profits Per Employee | 14,919 |
| Employee Count | 186 |
| Asset Turnover | 0.55 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSXV:LSL has paid 50,000 in taxes.
| Income Tax | 50,000 |
| Effective Tax Rate | 1.77% |
Stock Price Statistics
The stock price has decreased by -8.24% in the last 52 weeks. The beta is -0.29, so TSXV:LSL's price volatility has been lower than the market average.
| Beta (5Y) | -0.29 |
| 52-Week Price Change | -8.24% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 0.37 |
| Relative Strength Index (RSI) | 59.35 |
| Average Volume (20 Days) | 74,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:LSL had revenue of CAD 26.80 million and earned 2.78 million in profits. Earnings per share was 0.02.
| Revenue | 26.80M |
| Gross Profit | 7.97M |
| Operating Income | 1.42M |
| Pretax Income | 2.83M |
| Net Income | 2.78M |
| EBITDA | 3.80M |
| EBIT | 1.42M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 21.60M |
| Net Cash | -21.60M |
| Net Cash Per Share | -0.18 |
| Equity (Book Value) | 25.38M |
| Book Value Per Share | 0.22 |
| Working Capital | 7.12M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 29.73%, with operating and profit margins of 5.28% and 10.35%.
| Gross Margin | 29.73% |
| Operating Margin | 5.28% |
| Pretax Margin | 10.54% |
| Profit Margin | 10.35% |
| EBITDA Margin | 14.18% |
| EBIT Margin | 5.28% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:LSL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.11% |
| Shareholder Yield | -19.11% |
| Earnings Yield | 5.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |